In the Corona pandemic, BR50 already plays an important role as the voice of non-university research institutions in Berlin.
In dealing with the Corona pandemic, non-university research institutions also face enormous challenges. Many of them are dealing directly or indirectly with the pandemic and its effects. As employers, it is important to digitalize processes as far as possible and shift them to the home office. At the same time, institutions must make the conditions for researchers as secure as possible, for example with regard to the use of laboratories and other infrastructures. And last but not least, new ways must be found to enable the exchange among researchers that is essential for science.
As Interest Group Corona Task Force, the coordinators of the BR50 units closely exchange information on this. Based on this, BR50 advises the Senate Administration as a member of the Senate Task Force on how to deal with the corona pandemic in Berlin as a science hub. At the Berlin Science Week 2020, BR50 also held a public panel debate entitled How much home office can science take? to take stock of the changed research conditions in the context of a global pandemic.
In addition, the BR50 offices coordinated the distribution of the Covid-19 vaccine provided by the Berlin Senate for the non-university research institutions in Berlin. The vaccination campaign was successfully implemented in July and August 2021 in collaboration with the Charité.